reboxetine has been researched along with Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, G; Møller, M | 1 |
1 other study(ies) available for reboxetine and Multiple Sclerosis
| Article | Year |
|---|---|
Inhibition of selective noradrenergic reuptake as treatment of pathological laughter.
Topics: Adrenergic Uptake Inhibitors; Adult; Affective Symptoms; Humans; Laughter; Male; Middle Aged; Morpholines; Multiple Sclerosis; Reboxetine; Stroke | 2007 |